Skip to main content
Top
Published in: American Journal of Clinical Dermatology 1/2003

01-01-2003 | Pharmacovigilance

Cutaneous Drug Reaction Case Reports

From the World Literature

Published in: American Journal of Clinical Dermatology | Issue 1/2003

Login to get access

Excerpt

  • Abstract
  • 1. Angiotensin II Receptor Antagonists: Psoriasis
  • 2. Benzydamine: Photosensitive Dermatitis in an Elderly Patient
  • 3. Doxycycline/Minocycline/Tetracycline: Neutrophilic Dermatosis and Sweet’s Syndrome (First Report with Tetracycline)
  • 4. Etanercept: Accelerated Nodulosis and Vasculitis
  • 5. Fluorouracil: Hand-Foot Syndrome
  • 6. Gefitinib: Follicular Skin Eruptions
  • 7. Gemcitabine: Erysipeloid Skin Lesions
  • 8. Immunosuppressants: Angiosarcoma
  • 9. Infliximab: First Report of Erythema Multiforme and Lichenoid Eruption
  • 10. Infliximab: First Report of Systemic Lupus Erythematosus
  • 11. Interferon-α-2α: Systemic Sclerosis
  • 12. Interferon-α/Ribavirin: Sarcoidosis
  • 13. Levofloxacin: Acute Renal Failure and First Report of Purpura in an Elderly Patient
  • 14. Nimesulide: First Report of Pustulosis
  • 15. Paclitaxel: First Report of Scleroderma-like Reaction in an Elderly Patient
  • 16. Pyrazinamide: Skin Eruption
  • 17. Sirolimus: Delayed Wound Healing after Liver Transplant
  • 18. Zafirlukast: Churg-Strauss Syndrome
Footnotes
1
Reactions Weekly is the complete drug safety alerting service and summarizes information selected from over 1600 biomedical journals. This newsletter is produced by Adis International and is available in a variety of formats. Please contact your nearest Adis office for subscription details.
 
Literature
go back to reference Marquart-Elbaz C., Grosshans E., Alt M., et al. Sartans, angiotensin II receptor antagonists, can induce psoriasis. Br J Dermatol 2002 Sep; 147: 617–618 Marquart-Elbaz C., Grosshans E., Alt M., et al. Sartans, angiotensin II receptor antagonists, can induce psoriasis. Br J Dermatol 2002 Sep; 147: 617–618
go back to reference Henschel R., Agathos M., Breit R. Photocontact dermatitis after gargling with a solution containing benzydamine. Contact Dermatitis 2002 Jul; 47: 53PubMedCrossRef Henschel R., Agathos M., Breit R. Photocontact dermatitis after gargling with a solution containing benzydamine. Contact Dermatitis 2002 Jul; 47: 53PubMedCrossRef
go back to reference Durani B.K., Jappe U. Drug-induced Sweet’s syndrome in acne caused by different tetracyclines: case report and review of the literature. Br J Dermatol 2002 Sep; 147: 558–562CrossRef Durani B.K., Jappe U. Drug-induced Sweet’s syndrome in acne caused by different tetracyclines: case report and review of the literature. Br J Dermatol 2002 Sep; 147: 558–562CrossRef
go back to reference Cunnane G., Warnock M., Fye K.H., et al. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Care Res 2002 Aug; 47: 445–449CrossRef Cunnane G., Warnock M., Fye K.H., et al. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Care Res 2002 Aug; 47: 445–449CrossRef
go back to reference Gilbar P. Palmar-plantar erythrodysaesthesia associated with an initial course of bolus fluorouracil. J Pharm Pract Res 2002 Sep; 32: 178–179 Gilbar P. Palmar-plantar erythrodysaesthesia associated with an initial course of bolus fluorouracil. J Pharm Pract Res 2002 Sep; 32: 178–179
go back to reference Van Doorn R., Kirtschig G., Scheffer E., et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol 2002 Sep; 147: 598–601PubMedCrossRef Van Doorn R., Kirtschig G., Scheffer E., et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol 2002 Sep; 147: 598–601PubMedCrossRef
go back to reference Kuku I., Kaya E., Sevinc A., et al. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma. J Eur Acad Dermatol Venerol 2002 May; 16: 271–272CrossRef Kuku I., Kaya E., Sevinc A., et al. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma. J Eur Acad Dermatol Venerol 2002 May; 16: 271–272CrossRef
go back to reference Ahmed I., Hamacher K.L. Angiosarcoma in a chronically immunosuppressed renal transplant recipient: report of a case and review of the literature. Am J Dermatopathol 2002 Aug; 24: 330–335PubMedCrossRef Ahmed I., Hamacher K.L. Angiosarcoma in a chronically immunosuppressed renal transplant recipient: report of a case and review of the literature. Am J Dermatopathol 2002 Aug; 24: 330–335PubMedCrossRef
go back to reference Vergara G., Silvestre J.F., Betlloch I., et al. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002 Sep; 138: 1258–1259PubMedCrossRef Vergara G., Silvestre J.F., Betlloch I., et al. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002 Sep; 138: 1258–1259PubMedCrossRef
go back to reference Ali Y,, Shah S. Infliximab-induced systemic lupus erythematosus. Ann Intern Med 2002 Oct; 137: 625–626PubMed Ali Y,, Shah S. Infliximab-induced systemic lupus erythematosus. Ann Intern Med 2002 Oct; 137: 625–626PubMed
go back to reference Beretta L., Caronni M., Vanoli M., et al. Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 2002 Aug; 147: 385–386PubMedCrossRef Beretta L., Caronni M., Vanoli M., et al. Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 2002 Aug; 147: 385–386PubMedCrossRef
go back to reference Wendling J., Descamps V., Grossin M., et al. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 2002 Apr; 138: 546–547PubMedCrossRef Wendling J., Descamps V., Grossin M., et al. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 2002 Apr; 138: 546–547PubMedCrossRef
go back to reference Famularo G., De Simone C. Nephrotoxicity and purpura associated with levofloxacin. Ann Pharmacother 2002 Sep; 36: 1380–1382PubMedCrossRef Famularo G., De Simone C. Nephrotoxicity and purpura associated with levofloxacin. Ann Pharmacother 2002 Sep; 36: 1380–1382PubMedCrossRef
go back to reference Lateo S., Boffa M.J. Localized toxic pustuloderma associated with nimesulide therapy confirmed by patch testing. Br J Dermatol 2002 Sep; 147: 624–625PubMedCrossRef Lateo S., Boffa M.J. Localized toxic pustuloderma associated with nimesulide therapy confirmed by patch testing. Br J Dermatol 2002 Sep; 147: 624–625PubMedCrossRef
go back to reference Läuchli S., Trüeb R.M., Fehr M., et al. Scleroderma-like drug reaction to paclitaxel (Taxol Rm). Br J Dermatol 2002 Sep; 147: 619–621PubMedCrossRef Läuchli S., Trüeb R.M., Fehr M., et al. Scleroderma-like drug reaction to paclitaxel (Taxol Rm). Br J Dermatol 2002 Sep; 147: 619–621PubMedCrossRef
go back to reference Guilbeau J.M. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002 Sep; 36: 1391–1395PubMedCrossRef Guilbeau J.M. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002 Sep; 36: 1391–1395PubMedCrossRef
go back to reference Soy M., Ozer H., Canataroglu A., et al. Vasculitis induced by zafirlukast therapy. Clin Rheumatol 2002 Aug; 21: 328–329PubMedCrossRef Soy M., Ozer H., Canataroglu A., et al. Vasculitis induced by zafirlukast therapy. Clin Rheumatol 2002 Aug; 21: 328–329PubMedCrossRef
Metadata
Title
Cutaneous Drug Reaction Case Reports
From the World Literature
Publication date
01-01-2003
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 1/2003
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304010-00006

Other articles of this Issue 1/2003

American Journal of Clinical Dermatology 1/2003 Go to the issue

Adis Drug Evaluation

Terbinafine

Practical Dermatology

Drug-Induced Nail Abnormalities